Latest News

Search News
Categories
Archives
Combining medicine with blood cancer research

3rd September 2021

This Blood Cancer Awareness Month, we spoke with Dr John Riches, Clinical Senior Lecturer at Barts Cancer Institute (BCI), Queen Mary University of London. Dr Riches is a clinician scientist who splits his time between BCI where he leads a group researching blood cancer in our Centre for Haemato-Oncology and directs the MSc Cancer & Clinical Oncology Programme, and St Bartholemew’s Hospital where he treats blood cancer patients.

Read more

Miguel Ganuza receives ASH Global Research Award

24th August 2021

Congratulations to Dr Miguel Ganuza from Barts Cancer Institute, Queen Mary University of London, who has been selected by the American Society of Hematology (ASH) to receive the 2021 ASH Global Research Award. Dr Ganuza is one of twelve talented early-career investigators selected for this award.

Read more

HPV screening for cervical cancer prevention

3rd August 2021

Professor Jack Cuzick, Director of the Wolfson Institute of Preventive Medicine at Queen Mary University of London and Theme Lead for Cancer Prevention & Risk Reduction at the Cancer Research UK Barts Centre, has been awarded a Queen Mary Impact Award for his research on human papilloma virus (HPV) screening for cervical cancer, which has transformed cervical cancer prevention programmes worldwide.

Read more

Dissecting complex biological pathways with machine learning

19th July 2021

We spoke with Group Leader Dr Jun Wang and Postdoctoral Researcher Dr Anthony Anene from Barts Cancer Institute’s Centre for Cancer Genomics & Computational Biology about their most recent publication. Published in Patterns, the paper describes the development of a machine-learning tool called ACSNI that can be used to predict tissue-specific pathway components from large biological datasets.

Read more

Understanding centrosome amplification in cancer

12th July 2021

Dr Susana Godinho, Group Leader in the Centre for Cancer Cell & Molecular Biology at Barts Cancer Institute, Queen Mary University of London, has recently received a Cancer Research UK Discovery Programme Foundation Award. The award of approximately £1.4 million over 6 years will support a research project that will investigate the impact of centrosome amplification in cancer.

Read more

Immune cells assemble – boosting the effects of chemotherapy in pancreatic cancer

9th July 2021

A new study from Barts Cancer Institute, Queen Mary University of London, has demonstrated that immune cells can be stimulated to assemble into special structures within pancreatic cancer such that, at least in a pre-clinical model, researchers can demonstrate an improvement in the efficacy of chemotherapy.

Read more

Search News
Categories
Archives